Cargando…
From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
It is estimated that 25% of the world’s population has non-alcoholic fatty liver disease. This disease can advance to a more severe form, non-alcoholic steatohepatitis (NASH), a disease with a greater probability of progression to cirrhosis and hepatocellular carcinoma (HCC). NASH could be character...
Autores principales: | Rodríguez-Lara, Avilene, Rueda-Robles, Ascensión, Sáez-Lara, María José, Plaza-Diaz, Julio, Álvarez-Mercado, Ana I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385788/ https://www.ncbi.nlm.nih.gov/pubmed/37513787 http://dx.doi.org/10.3390/pathogens12070940 |
Ejemplares similares
-
Effect of Probiotics on Host-Microbiota in Bacterial Infections
por: Rueda-Robles, Ascensión, et al.
Publicado: (2022) -
Impact of Dietary Patterns on H. pylori Infection and the Modulation of Microbiota to Counteract Its Effect. A Narrative Review
por: Rueda-Robles, Ascensión, et al.
Publicado: (2021) -
Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials
por: Sáez-Lara, Maria Jose, et al.
Publicado: (2016) -
Microbiota, a key player in alcoholic liver disease
por: Cassard, Anne-Marie, et al.
Publicado: (2018) -
Editorial: Interplay between gut microbiota and the immune system in liver surgery and liver diseases
por: Plaza-Díaz, Julio, et al.
Publicado: (2023)